Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 3:23 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–107 of 107 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Amnesia-Memory Loss Clear all

Conditions: Sleep Disturbance, Dementia
Interventions: Cognitive Behavioral Therapy for Insomnia; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Mild Cognitive Impairment, Alzheimer's Disease, Alzheimer's Disease, Early Onset, Memory Loss, Memory Disorders, Memory Impairment
Interventions: Biomarker Data Collection, MK6240; Other · Radiation
Lead sponsor: GAP Innovations, PBC; Industry
Eligibility: 60 Years to 90 Years
Enrollment: 1,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 22
States / cities: Atlantis, Florida • Aventura, Florida • Clermont, Florida + 19 more

Conditions: Alzheimer Disease, Mild Cognitive Impairment, Memory Loss, Memory Disorders, Memory Impairment
Interventions: Prescreener database; Other
Lead sponsor: Global Alzheimer's Platform Foundation; Other
Eligibility: 50 Years to 90 Years
Enrollment: 1,555 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 18
States / cities: San Diego, California • Santa Ana, California • Aventura, Florida + 13 more

Conditions: Dementia, Memory Loss, Caregiver
Interventions: Tracking/finding system; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Glioblastoma, Radiotherapy; Complications, Cognitive Decline, Chemoradiation
Interventions: Ramipril; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 422
States / cities: Anchorage, Alaska • Phoenix, Arizona • Fort Smith, Arkansas + 280 more

Conditions: Amnesia, Dementia, Healthy, Nervous System Disease
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 830 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1992 – 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Mild Cognitive Impairment, Memory Loss
Interventions: Transcranial magnetic stimulation; Device
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Dementia, Alzheimer's Disease, Parkinson Disease, Huntington Disease
Interventions: Not listed
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Memory Loss
Interventions: Donepezil Hydrochloride, Placebo; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 45 Years to 90 Years
Enrollment: 821 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 54
States / cities: Albaster, Alabama • Mesa, Arizona • Peoria, Arizona + 51 more

Conditions: Hypertension, Cognitive Decline
Interventions: Virtual Collaborative Care Clinic; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 65 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Cognition Disorders
Interventions: Placebo, Solanezumab; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 65 Years to 85 Years
Enrollment: 1,169 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2023
U.S. locations: 62
States / cities: Birmingham, Alabama • Phoenix, Arizona • Sun City, Arizona + 47 more

Search by objective public record fields.

Sleep Enhancement for Older Adults Living With Memory Loss And Their Care Partners

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Identification of Patients With a High Probability of Meeting Eligibility Criteria for an Alzheimer's Disease Clinical Trial (APHELEIA)

Evaluating a Wearable Tracking System for Family Caregivers of Persons With Dementia With Wandering Concerns

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders

Targeted Transcranial Magnetic Stimulation to Improve Hippocampal-dependent Declarative Memory Abilities

Memory Disorders Registry

The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)

Remote Monitoring and Virtual Collaborative Care For Hypertension Control To Prevent Cognitive Decline

Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss